Andrew Feldman, M.D., Named Vice Chair of Research
Andrew L. Feldman, M.D., has been appointed the new Vice Chair of Research in Rochester, effective October 1, 2015.
In this role, Dr. Feldman will partner with Research Services Administrator Ken Saling to drive innovation within the department and provide planning, oversight, and guidance of research in Mayo Clinic's Department of Laboratory Medicine and Pathology (DLMP) divisions and for individual consultant investigators. The role will be expected to promote the research and translational goals of DLMP and increase collaboration with Mayo Clinic's Center for Individualized Medicine, Center for Regenerative Medicine, and Center for the Science of Health Care Delivery to meet these goals. The Vice Chair of Research, with the administrator, will provide guidance and advice to increase extramural funding for research within DLMP and advocate for DLMP research with institutional research committees, centers, and other departments and divisions. Dr. Feldman will chair the DLMP Research Committee that allocates internal funding to support scholarly activities in the department.
Dr. Feldman joined the staff of Mayo Clinic in Rochester in 2006 as a Senior Associate Consultant. He is now a Consultant in the Department of Laboratory Medicine and Pathology with joint appointments in the Divisions of Hematopathology, Anatomic Pathology, and Experimental Pathology. He holds the academic rank of Associate Professor of Laboratory Medicine and Pathology.
Dr. Feldman’s research interests include the genetics and biology of T-cell lymphoma and lymphoma therapeutic targets and biomarkers. His team’s long-term goal is to improve the lives of patients with lymphoma through individualized therapy guided by new theranostic laboratory tests that predict efficacy of targeted therapeutic approaches.
Dr. Feldman has received many honors and awards including the Fellows Award for Research Excellence from the National Institutes of Health, the Artemis Fellowship from the Nikolas Symposium XV in Athens, Greece, and, most recently, the 2015 Berard-Dorfman Founders Award from the Society for Hematopathology.
Dr. Feldman received his B.A. and M.D. degrees from Brown University. After initial training in surgery and serving as a Medical Staff Fellow in Surgical Oncology at the National Cancer Institute, he completed a residency in Anatomic Pathology and a fellowship in Hematopathology, also at the National Cancer Institute.